TITAN MEDICAL INC. overview

TORONTO, Ontario, Oct. 08, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that, in connection with its amalgamation agreement (“ Amalgamation Agreement ”) with Conavi Medical Inc. (“ Conavi ”) providing for the combination of the companies in an all-stock transaction (the “ Transaction ”), Conavi has closed its previously announced concurrent private placement of subscription receipts (“ Subscription Receipts ”) for gross...

TORONTO, Ontario, Oct. 02, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that following its annual general meeting held on September 30, 2024 (the “ Meeting ”) and in accordance with Titan’s Majority Voting Policy (the “ Voting Policy ”), Anthony Giovinazzo, Cathy Steiner, Cary Vance and Paul Cataford have tendered to the Board of Directors (the “ Board ”) their resignations as directors of Titan (including Paul Cataford’s...

TORONTO, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announced the voting results from its Annual General and Special Meeting of Shareholders (the “ AGM ”) held virtually via live audio webcast on September 30, 2024. Shareholders voted in favour of all management resolutions proposed in Titan’s management information circular dated August 30, 2024 (the “ Circular ”). Resolutions proposed and approved at the AGM include: fixing...

TORONTO, Ontario, Sept. 30, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) announces that its board of directors (the “ Board ”) has approved the voluntary delisting (the “ Delisting ”) of Titan’s common shares (the “ Titan Shares ”) from the Toronto Stock Exchange (the “ TSX ”). Subject to approval by the TSX and the completion of all closing conditions for the Transaction (defined below) it is expected that the Titan Shares will be delisted...

TORONTO, Ontario, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that Conavi Medical Inc. (“ Conavi ”) has received the requisite shareholder approval required to proceed with the proposed combination of Titan and Conavi (the “ Amalgamation ”) in an all-stock transaction (the “ Transaction ”). This Transaction will constitute a reverse takeover of Titan. The Conavi shareholder approval of the Amalgamation was...

TORONTO, Ontario, Sept. 25, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) released a reminder for shareholders to vote ahead of Titan’s annual and special shareholders meeting (the “ Meeting ”) scheduled to be held on Monday, September 30, 2024. Less than half of the Titan common shares have been voted in advance of the Meeting. VOTE TODAY. The Management Information Circular (the “ Circular ”) and related materials for the Meeting are available on...

TORONTO, Ontario, Sept. 19, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that a second independent proxy advisor, Glass Lewis has recommended that their clients to vote their shares FOR the proposed amalgamation with Conavi Medical Inc. (the “ Amalgamation ”) at the annual general and special meeting of Titan to be held on September 30, 2024 (the “ Meeting ”). Glass Lewis is the second leading independent proxy advisory firm to...

TORONTO, Ontario, Sept. 16, 2024 (GLOBE NEWSWIRE) -- Titan Medical Inc. (“ Titan ”) (TSX: TMD; OTC: TMDIF) is pleased to announce that Institutional Shareholder Services (“ ISS ”), has released a report (the " ISS Report ") recommending that Titan’s shareholders (" Shareholders ") vote in favour of the proposed amalgamation with Conavi Medical Inc. (the “ Amalgamation ”) to be approved by the Shareholders at the annual general and special meeting of Titan to be held on September...